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thane patch. Using multivariate Cox regression analysis, we
found that restenosis of50% was associated with primacy
closure (P  0.01).
Previous studies have suggested that recurrent stenosis
might be connected to gender, with a higher rate of reste-
nosis in women.15,19, 22-24 In a study by Ricco et al,18
women with patch closure (knitted polyester patch impreg-
nated with collagen) had a higher rate of restenosis than did
men. This result is similar to the results in this study where
women in the polyester urethane patch group had a higher
rate of restenosis (50%) (P  .04, hazard ratio, 4.2; 95%
CI (1.06 to 16.51). A larger sample size might aid in
further evaluating the interaction between patch and gen-
der, especially in this synthetic patch.
One patient (4.2%) with restenosis was symptomatic.
This finding is similar to the literature19-21 and may be
explained by the gradual development of the restenosis,
usually due to intimal hyperplasia, without macroulcer-
ations that may be responsible for neurologic symptoms in
carotid stenosis caused by arteriosclerosis. The decision on
how to treat patients with recurrent carotid artery stenosis
must be influenced by this and by the high complication
rate of a reoperation. We prefer to treat these patients with
a carotid stent and only when there is a contralateral occlu-
sion or the patients are symptomatic.
In conclusion, this randomized prospective study has
shown that carotid patch angioplasty with a polyester ure-
thane patch has good postoperative results with a low rate
of immediate postoperative complications and, compared
with primary closure, has a much lower rate of restenosis.
We thank Ofra Barnett-Griness, PhD, for help with the
statistical analysis of this study.
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In this prospective randomized trial, the outcomes of 216 polyurethane-patched CEAs were compared. The perioperativemortality and neurologic event rates were low and similar in both
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similar trials, the meta-analysis will probably continue to show that
patching gives statistically significant lower rates of perioperative
stroke and death than does primary closure.
The authors chose residual stenosis and recurrent stenosis as
their major end-points because the occurrence rates of these two
outcomes are high enough with a study size of 400 to obtain
adequate statistical power. The 50% residual stenosis rate was
1.1% in the patched group and 8.9% with primary closure (P
.001). This illustrates one of the recognized problems with fre-
quent or obligatory primary closure, namely a high residual steno-
sis or occlusion rate. The 8.9% rate of residual stenosis in the
primary closure group was obtained despite the exclusion of 24
patients from the study because of operative findings of a small
internal carotid or the necessity for an interposition bypass.
Excluding the residual stenotic CEAs, the 2-year Kaplan-
Meier rate for 70% recurrent stenosis for the polyurethane-
patched CEAs was 2.2% versus 8.6% for primary closure (P .01)
and for50%was 4.9% versus 13.6% for primary closure (P .01).
Other studies and a Cochrane Review have similar statisticallysignificant results for patching versus primary closure, with the
clinical implication that obligatory or frequent primary closure is
not advisable. The relatively low recurrent stenosis rate for
polyurethane-patched CEAs may be important. In other studies,
collagen-impregnated Dacron, a commonly used patch, had con-
siderably higher restenosis rates. Further, the relatively low recur-
rent stenosis rates for polyurethane-patched CEAs approach those
that others have obtained with greater saphenous vein patching.
Identifying the optimal CEA patchmaterial continues to be an
ongoing topic of investigation. Because the probability of a recur-
rent stenosis becoming symptomatic is low, some surgeons do not
consider this a major problem. I disagree, particularly for patients
operated on for asymptomatic stenosis, which is now by far the
most frequently used indication for performing CEA, as recurrent
stenosis defeats the primary reason for operation. Even though a
recent Cochrane Review meta-analysis demonstrated little differ-
ence in restenosis rates between various patch materials, the chal-
lenge to identify the best material continues, and polyurethane
could be a serious contender in the synthetic category.
